We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Tdap Vaccination for Infant Caregivers

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01233401
First Posted: November 3, 2010
Last Update Posted: July 28, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Saint Raphael Healthcare System
Information provided by:
Yale University
  Purpose
This study evaluates whether offering Tetanus, diphteria and acellular pertussis (Tdap) vaccine to caregivers of newborn infants during pediatric well child visits increase the caregivers' vaccination rates.

Condition Intervention
Pertussis Vaccination Other: Survey

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Cross-Sectional
Official Title: Tdap Vaccination for Infant Caregivers in the Pediatric Office

Resource links provided by NLM:


Further study details as provided by Yale University:

Primary Outcome Measures:
  • Maternal Tdap Vaccination Rate [ Time Frame: At 2 week well child visit ]

Secondary Outcome Measures:
  • Other Infant Caregiver Tdap Vaccination Rate [ Time Frame: At 2 week well child visit ]

Enrollment: 102
Study Start Date: June 2010
Study Completion Date: June 2011
Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Mothers Other: Survey
Mothers and Other infant caregivers are surveyed at the end of the 2 week newborn well child visit about whether they chose to receive the Tdap vaccine at the pediatrician's office.
Other Infant Caregivers
Includes fathers, grandparents, and other adults who are infant caregivers
Other: Survey
Mothers and Other infant caregivers are surveyed at the end of the 2 week newborn well child visit about whether they chose to receive the Tdap vaccine at the pediatrician's office.

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 64 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
18-64 year old men and women who are mothers or other infant caregivers of 2 week old infants
Criteria

Inclusion Criteria:

  • 18-64 years old
  • English or Spanish speaking

Exclusion Criteria:

  • Do not speak English or Spanish
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01233401


Locations
United States, Connecticut
Hospital of St. Raphael
New Haven, Connecticut, United States, 06511
Sponsors and Collaborators
Yale University
Saint Raphael Healthcare System
Investigators
Principal Investigator: Deepa R Camenga, MD Yale University
Principal Investigator: Marjorie Rosenthal, MD MPH Yale University
  More Information

Responsible Party: Deepa Camenga, MD, Yale University
ClinicalTrials.gov Identifier: NCT01233401     History of Changes
Other Study ID Numbers: 1005006837
First Submitted: November 1, 2010
First Posted: November 3, 2010
Last Update Posted: July 28, 2011
Last Verified: July 2011

Keywords provided by Yale University:
Pertussis, Vaccination, Adult

Additional relevant MeSH terms:
Whooping Cough
Bordetella Infections
Gram-Negative Bacterial Infections
Bacterial Infections
Respiratory Tract Infections
Infection
Respiratory Tract Diseases
Vaccines
Immunologic Factors
Physiological Effects of Drugs